Gain Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GANX and other ETFs, options, and stocks.About GANX
Gain Therapeutics, Inc. is a redefining drug discovery company, which identifies and optimizes allosteric binding sites that never targeted before. Its See-Tx target identification platform uses the published 3D structure of enzymes and a proprietary computational technology to discover new allosteric binding sites and predict their druggability.
CEOGene C. Mack
CEOGene C. Mack
Employees25
Employees25
HeadquartersBethesda, Maryland
HeadquartersBethesda, Maryland
Founded2017
Founded2017
Employees25
Employees25
GANX Key Statistics
Market cap47.51M
Market cap47.51M
Price-Earnings ratio-1.81
Price-Earnings ratio-1.81
Dividend yield—
Dividend yield—
Average volume328.38K
Average volume328.38K
High today$1.64
High today$1.64
Low today$1.57
Low today$1.57
Open price$1.61
Open price$1.61
Volume209.88K
Volume209.88K
52 Week high$3.19
52 Week high$3.19
52 Week low$0.89
52 Week low$0.89
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own GANX. This list is generated using Robinhood data, and it’s not a recommendation.